Virgin Galactic Holdings (SPCE) surged over 22% to $5.58 during Friday, May 29, 2026, trading as investors responded to successful flight-testing updates and growing excitement surrounding the expected SpaceX initial public offering. The rally pushed SPCE far ahead of the broader industrial sector, which slipped 0.16%, while the S&P 500 gained just 0.31%. The stock has more than doubled from recent lows near $2.50, driven by the company's first return to flight operations in nearly two years and sector-wide momentum from SpaceX IPO speculation at a $1.75-$2 Trillion valuation.
Virgin Galactic Resumes VSS Unity Glide Flight Testing After Two-Year Pause
Virgin Galactic recently resumed glide flight testing with its VSS Unity spacecraft at Spaceport America. The successful test marked the company's first return to flight operations in nearly two years. The glide test did not include rocket-powered spaceflight. VSS Unity separated from its mothership and safely glided back to Earth. Management continues to target Q3 2026 for additional glide testing of its next-generation Delta-class spacecraft. The company also maintains plans for commercial flights to begin during the fourth quarter of 2026.
SpaceX IPO Speculation Drives Space Sector Rally
Retail investors have flooded into space-related stocks amid reports that SpaceX could pursue a public listing at a valuation of $1.75-$2 Trillion. That enthusiasm has created strong momentum across speculative aerospace names, with Virgin Galactic emerging as one of the biggest beneficiaries. Many traders now view SPCE as a proxy trade for broader space industry excitement while waiting for potential SpaceX IPO developments. The renewed attention has significantly increased trading volume and volatility across the stock.
Federal Court Grants Preliminary Approval for $2.75 Million Shareholder Lawsuit Settlement
Virgin Galactic announced that a federal court granted preliminary approval for a settlement tied to shareholder derivative lawsuits dating back to 2022. Under the agreement, insurers will pay approximately $2.75 million to resolve the litigation. The financial amount itself remains relatively small. However, the bigger impact comes from reducing legal uncertainty that had weighed on investor sentiment for years.
Virgin Galactic Targets Q3 2026 Delta-Class Testing and Q4 Commercial Flights
Investors continue to watch progress surrounding Virgin Galactic's next-generation Delta-class spacecraft program. The company aims to transition away from limited VSS Unity flights toward scalable commercial operations capable of supporting higher-frequency launches and improved economics. Virgin Galactic recently reopened ticket sales at $750,000 per seat as it prepares for future operations. Jefferies reiterated a Buy rating on the stock and maintained a $5 price target, pointing to improving operational milestones and sufficient near-term liquidity.
Virgin Galactic Continues Operating at Negative Cash Flow Despite Rally
Virgin Galactic continues facing major financial challenges. The company still generates minimal revenue and remains deeply unprofitable. Free cash flow stayed negative during the latest quarter, while operating losses remain substantial as the company continues funding spacecraft development and testing.
FAQ
What caused Virgin Galactic stock to surge 22% on May 29, 2026?
Virgin Galactic stock surged over 22% to $5.58 on Friday, May 29, 2026, driven by the company's successful resumption of glide flight testing with its VSS Unity spacecraft after a two-year pause and growing investor excitement surrounding the expected SpaceX initial public offering at a valuation of $1.75-$2 Trillion.
When does Virgin Galactic plan to begin commercial flights?
Virgin Galactic maintains plans for commercial flights to begin during the fourth quarter of 2026. The company continues to target Q3 2026 for additional glide testing of its next-generation Delta-class spacecraft and recently reopened ticket sales at $750,000 per seat.
What was the outcome of Virgin Galactic's shareholder lawsuit settlement?
A federal court granted preliminary approval for a settlement tied to shareholder derivative lawsuits dating back to 2022. Under the agreement, insurers will pay approximately $2.75 million to resolve the litigation, reducing legal uncertainty that had weighed on investor sentiment.
